
Progenity, Inc. PROG
Progenity, Inc. Operating Cycle | PROG
Annual Operating Cycle Progenity, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 879 | 1.02 K | 1.19 K | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.19 K | 879 | 1.03 K |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Brickell Biotech
BBI
|
26 | - | -5.38 % | $ 6.06 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
107 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
18.6 | - | - | $ 5.78 B | ||
|
AbbVie
ABBV
|
350 | $ 294.72 | 0.32 % | $ 521 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
33.4 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Axon Enterprise
AXON
|
98.8 | $ 316.97 | 4.77 % | $ 24.7 B | ||
|
Bristol-Myers Squibb Company
BMY
|
153 | $ 62.89 | 0.18 % | $ 128 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
19.1 K | - | -15.15 % | $ 60.3 M | ||
|
Dynavax Technologies Corporation
DVAX
|
512 | - | - | $ 2.02 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
86.7 | $ 159.75 | 5.35 % | $ 20.9 B | ||
|
Amgen
AMGN
|
282 | $ 467.97 | 0.59 % | $ 252 B | ||
|
Orgenesis
ORGS
|
25.8 | - | -33.86 % | $ 61.2 M | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
66.2 | $ 248.31 | 1.17 % | $ 15.1 B | ||
|
Johnson & Johnson
JNJ
|
223 | $ 280.31 | -0.17 % | $ 675 B | ||
|
Kala Pharmaceuticals
KALA
|
729 | $ 0.17 | 0.64 % | $ 1.39 M | ||
|
Sage Therapeutics
SAGE
|
408 | - | - | $ 527 M | ||
|
Lineage Cell Therapeutics
LCTX
|
19.2 | $ 1.13 | 8.17 % | $ 260 M | ||
|
Paratek Pharmaceuticals
PRTK
|
337 | - | - | $ 121 M | ||
|
Eli Lilly and Company
LLY
|
433 | $ 1 437.4 | 0.36 % | $ 1.29 T | ||
|
Compugen Ltd.
CGEN
|
400 | $ 2.09 | -0.24 % | $ 195 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
554 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
GeoVax Labs
GOVX
|
48.4 | $ 2.13 | -20.4 % | $ 2.04 M | ||
|
AVEO Pharmaceuticals
AVEO
|
263 | - | - | $ 521 M | ||
|
Seelos Therapeutics
SEEL
|
63.2 | - | -47.76 % | $ 6.27 M | ||
|
Celldex Therapeutics
CLDX
|
43.4 | $ 30.18 | -1.53 % | $ 2 B | ||
|
Moderna
MRNA
|
108 | $ 248.62 | -0.88 % | $ 96.7 B |